FOR IN VITRO LABORATORY USE ONLY.
WARRANTY: VMRD, Inc. warrants that this product is as described in the quantity and contents stated on the label at the
time of delivery to the customer. NO OTHER WARRANTIES, EXPRESS OR IMPLIED, ARE MADE BEYOND THE LABEL
DESCRIPTION, INCLUDING WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR USE. Remedy
is limited to replacement of the pro
duct or refund of the purchase price. VMRD, Inc. is not liable for property damage, personal injury, or economic loss caused by the product. The information listed in this information sheet is provided for
reference only,
and should not be substituted for the user’s own incoming material qua
lity control.
H:
Quality VMRD
QC
CofA
Coombs
Equine Coombs
492-2 P091005-001 140222.docx
25 February 2012
VMR
Telephone: 509-334-5815
Fax: 509-332-5356
E-mail:
vmrd@vmrd.com
PO Box 502, Pullman, WA 99163 USA
Web site:
http://www.vmrd.com
Certificate of Analysis
EQUINE COOMBS REAGENT
CATALOG NO.:
492-2
VOLUME:
2 ml
LOT:
P091005-001
EXPIRATION DATE:
22 February 2014
INTRODUCTION: The equine Coombs test, also called direct antiglobulin test, is designed to detect immune-mediated
erythrocyte destruction which occurs in autoimmune hemolytic anemia, and in some cases with infections and neoplastic
disorders, in neonatal isoerythrolysis.
Hemolysis in these d
iseas
es is caused by the erythrocytes being coated with antibody (IgG, IgM) and/or complement components (C3). Coated erythrocytes are lysed in the bloodstream and/or removed by
phagocytes.
The Coombs reagent is an antiserum to equine IgG, IgM, and C3 prepared in goats. After obtaining the antiserum,
complement is inactivated at 56C for 30 minutes and then the antiserum is absorbed repeatedly with washed normal equine
erythrocytes. These treatments ensure that the Coombs reagen
t will not react with normal equine erythrocytes. However, equine erythrocytes that are coated with IgG, IgM, and/or C3 will be agglutinated by the Coombs reagent because it contains
antibodies to equine IgG, IgM, and C3.
QUALITY CONTROL METHOD: Washed sheep red blood cells (SRBC) were sensitized with the Equine Coombs
Positive Control (catalog no. 472-2). The procedure is performed according to the Coombs Positive Control Procedure. The
Equine Coombs Reagent was tested according to the Equine Coombs Reagent Procedure.
Specific Reaction:
The Coombs reagent produced agglutination on sensitized SRBCs of 1+ agglutination at
1/2, 1-2+ at 1/4 and +/- agglutination at 1/8. No agglutination on unsensitized SRBCs.
Other Comments:
The subagglutinating dose for the equine positive control was determined to be 1/8.
When using the positive control this dose may vary under your laboratory conditions and
especially with your source of sheep red blood cells. Therefore, we recommend that you
titer the positive control with your own SRBCs before using it. Please refer to Section A
of the Coombs Positive Control procedure.
INDICATIONS FOR TEST: Horses with anemia (including that caused by intravascular and extravascular hemolysis) of
unknown origin are reasonable candidates for evaluation by Coombs testing. Foals with neonatal isoerythrolysis are often
Coombs positive.
PRECAUTIONS: Use the reagent at the dilutions described in the procedure to avoid nonspecific and prozone effects.
STORAGE:
Store at <–10ºC until expiration date or at 2-7ºC if used within 6 months of opening.
REFERENCES:
McGuire, T.C., et al. Complement (C3)-coated red blood cells following infection with the virus of equine infectious
anemia. J. Immunology 103:239-299 (1969).
Anderson, I.J. Idiopathic autoimmune haemolytic anemia in the horse. New Zealand Vet. J. 22:102 (1974).
2